Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452413
Status:
COMPLETED
Last Update Posted:
2021-05-13
First Post:
2007-03-23
Brief Title:
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-23
First Submit QC Date:
March 26 2007
Study First Post Date:
2007-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-05-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-05-27
Disp First Submit QC Date:
May 27 2010
Disp First Post Date:
2010-06-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-04-20
Last Update Post Date:
2021-05-13
Last Update Post Date Type:
ACTUAL